First human doses of ORKA-001 given to healthy volunteers
NCT ID NCT06698939
First seen Apr 02, 2026 · Last updated May 24, 2026 · Updated 7 times
Summary
This study tested a single dose of a new drug called ORKA-001 in 24 healthy adults aged 18 to 65. The main goal was to check if the drug is safe and how the body processes it. No treatment for any disease was being tested—just basic safety information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Oruka Therapeutics Investigative Site
Christchurch, New Zealand
Conditions
Explore the condition pages connected to this study.